IT dept detects Rs 550-cr hidden income after raids on Hetero pharma group; Rs 142-cr cash seized
PTI, Oct 9, 2021, 2:31 PM IST
Image for representation
New Delhi: The Income Tax Department detected “unaccounted” income of Rs 550 crore and seized over Rs 142 crore cash after it recently raided Hyderabad-based Hetero pharmaceutical group, official sources claimed on Saturday.
Company officials were not immediately available for comments.
The raids were carried out by the tax department on October 6 at about 50 locations in half a dozen states.
“During the search, several bank lockers have been found, out of which 16 lockers have been operated. The searches have resulted in the seizure of unexplained cash amounting to Rs 142.87 crore, so far,” the Central Board of Direct Taxes (CBDT) said in a statement.
“Unaccounted income unearthed is estimated to be in the range of about Rs 550 crore till now,” it said.
Official sources identified it as the Hetero pharma group of Hyderabad.
Further investigations and quantification of undisclosed income detected is in progress, it added.
The CBDT frames policy for the Income Tax Department.
The CBDT said the group is engaged in the business of manufacturing intermediates, active pharmaceutical ingredients (APIs), and formulations, and the majority of the products are exported to countries like the US and Dubai and some African and European countries.
“Issues relating to discrepancies in purchases made from bogus and non-existent entities and artificial inflation of certain heads of expenditure were detected. Further, evidence of on-money payment for the purchase of lands was also found,” it claimed.
Various other legal issues were also identified such as personal expenses being booked in the company’s books and land purchased by related parties “below government registration value.”
It alleged that hideouts were identified during the raids where the second set of books of accounts and cash were found.
“Incriminating evidence in the form of digital media, pen drives, documents, etc. have been found and seized and digital “evidences” were gathered from SAP and ERP software maintained by the assessee group,” it said.
Hetero shot into the limelight after the group signed several agreements and undertook the development of various drugs such as Remdesivir and Favipiravir to treat COVID-19.
It has over 25 manufacturing facilities located in India, China, Russia, Egypt, Mexico, and Iran.
The company last month had said that it had received Emergency Use Authorisation from the Drug Controller General of India (DCGI) for its biosimilar version of Tocilizumab for treatment of COVID-19 in hospitalized adults.
The Rs 7,500 crore pharma major is one of the firms that has tied up with the Russian Direct Investment Fund to manufacture COVID-19 vaccine Sputnik V in India.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Four-day market rally makes investors richer by Rs 8.48 lakh crore
Kotak Bank barred from onboarding customers online, issuing fresh credit cards
Reverse migration has begun, says FM Nirmala Sitharaman
Markets sustain winning streak — Sensex jumps over 560 points, Nifty tops 22,300-level
Sensex climbs 640 points, Nifty tops 22,300-level in early trade
MUST WATCH
Latest Additions
WATCH: 5 runaway military horses cause mayhem in London
FIR filed over BJP’s social media post allegedly promoting hatred and enmity: EC
Can’t control elections or pass directions on basis of suspicion: SC tells EVM critics
Amitabh Bachchan receives Lata Deenanath Mangeshkar Puraskar
Hubballi: Congress leader Randeep Surjewala visits Neha’s house, assures justice to family